StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.76−0.02 (-2.11%)

Close on Nov 17, 2026Market cap $256.61MP/E –Yield –

Ocugen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ocugen's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.87M. For fiscal 2025 it was -$56.96M. The highest annual figure on record is -$11.63M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$56.96M–
FY2024Dec 31, 2024-$42.14M–
FY2023Dec 31, 2023-$62.05M–
FY2022Dec 31, 2022-$60.08M–
FY2021Dec 31, 2021-$47.94M–
FY2020Dec 31, 2020-$14.71M–
FY2019Dec 31, 2019-$16.89M–
FY2018Dec 31, 2018-$11.63M–
FY2017Dec 31, 2017-$23.02M–
FY2016Dec 31, 2016-$25.74M–
FY2015Dec 31, 2015-$30.03M–
FY2014Dec 31, 2014-$17.94M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.20M–
Q1 FY2026Mar 31, 2026-$21.79M–
Q4 FY2025Dec 31, 2025-$13.96M–
Q3 FY2025Sep 30, 2025-$12.92M–
Q2 FY2025Jun 30, 2025-$10.73M–
Q1 FY2025Mar 31, 2025-$19.36M–
Q4 FY2024Dec 31, 2024-$10.36M–
Q3 FY2024Sep 30, 2024-$11.27M–
Q2 FY2024Jun 30, 2024-$9.91M–
Q1 FY2024Mar 31, 2024-$10.60M–
Q4 FY2023Dec 31, 2023-$11.30M–
Q3 FY2023Sep 30, 2023-$13.71M–
Q2 FY2023Jun 30, 2023-$18.81M–
Q1 FY2023Mar 31, 2023-$18.24M–
Q4 FY2022Dec 31, 2022-$16.91M–
Q3 FY2022Sep 30, 2022-$14.30M–
Q2 FY2022Jun 30, 2022-$13.80M–
Q1 FY2022Mar 31, 2022-$15.07M–
Q4 FY2021Dec 31, 2021-$12.80M–
Q3 FY2021Sep 30, 2021-$8.05M–
Q2 FY2021Jun 30, 2021-$21.80M–
Q1 FY2021Mar 31, 2021-$5.28M–
Q4 FY2020Dec 31, 2020-$4.28M–
Q3 FY2020Sep 30, 2020-$2.65M–
Q2 FY2020Jun 30, 2020-$3.09M–
Q1 FY2020Mar 31, 2020-$4.69M–
Q4 FY2019Dec 31, 2019-$8.74M–
Q3 FY2019Sep 30, 2019-$2.12M–
Q2 FY2019Jun 30, 2019-$3.36M–
Q1 FY2019Mar 31, 2019-$2.67M-181.2%
Q4 FY2018Dec 31, 2018-$2.79M–
Q3 FY2018Sep 30, 2018-$6.92M–
Q2 FY2018Jun 30, 2018-$5.21M–
Q1 FY2018Mar 31, 2018$3.29M–
Q4 FY2017Dec 31, 2017-$4.32M–
Q3 FY2017Sep 30, 2017-$5.73M–
Q2 FY2017Jun 30, 2017-$5.63M–
Q1 FY2017Mar 31, 2017-$7.35M–
Q4 FY2016Dec 31, 2016-$5.89M–
Q3 FY2016Sep 30, 2016-$5.46M–

More Ocugen figures

See a number that looks wrong?